25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Daesung Microbiological Labs. Co. Ltd
Buy, Hold or Sell?

Let's analyze Daesung Microbiological Labs. Co. Ltd together

I guess you are interested in Daesung Microbiological Labs. Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Daesung Microbiological Labs. Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Daesung Microbiological Labs. Co. Ltd

I send you an email if I find something interesting about Daesung Microbiological Labs. Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Daesung Microbiological Labs. Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Daesung Microbiological Labs. Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
69.7%

What is your share worth?

Current worth
₩9,377.39
Expected worth in 1 year
₩8,479.63
How sure are you?
78.8%

+ What do you gain per year?

Total Gains per Share
₩-897.76
Return On Investment
-9.5%

For what price can you sell your share?

Current Price per Share
₩9,420.00
Expected price per share
₩8,460 - ₩9,830
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Daesung Microbiological Labs. Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩9,420.00

2.2. Growth of Daesung Microbiological Labs. Co. Ltd (5 min.)




Is Daesung Microbiological Labs. Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$24.9m$27.1m-$1.2m-5.0%

How much money is Daesung Microbiological Labs. Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$455.4k$77.1k-$532.5k-116.9%
Net Profit Margin-11.5%1.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Daesung Microbiological Labs. Co. Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Daesung Microbiological Labs. Co. Ltd?

Welcome investor! Daesung Microbiological Labs. Co. Ltd's management wants to use your money to grow the business. In return you get a share of Daesung Microbiological Labs. Co. Ltd.

First you should know what it really means to hold a share of Daesung Microbiological Labs. Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Daesung Microbiological Labs. Co. Ltd is ₩9,420. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Daesung Microbiological Labs. Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Daesung Microbiological Labs. Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩9,377.39. Based on the TTM, the Book Value Change Per Share is ₩-224.44 per quarter. Based on the YOY, the Book Value Change Per Share is ₩37.58 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Daesung Microbiological Labs. Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.210.0%-0.120.0%0.020.0%0.020.0%0.080.0%
Usd Book Value Change Per Share-0.210.0%-0.160.0%0.030.0%0.010.0%0.200.0%
Usd Dividend Per Share0.000.0%0.000.0%0.040.0%0.040.0%0.040.0%
Usd Total Gains Per Share-0.210.0%-0.160.0%0.070.0%0.050.0%0.240.0%
Usd Price Per Share7.25-7.40-7.24-9.63-28.91-
Price to Earnings Ratio-8.83--74.28--193.82-17.96-81.11-
Price-to-Total Gains Ratio-35.31--52.66--3.84--191.89-82.61-
Price to Book Ratio1.10-1.09-1.01-1.42-5.39-
Price-to-Total Gains Ratio-35.31--52.66--3.84--191.89-82.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.594
Number of shares151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.160.01
Usd Total Gains Per Share-0.160.05
Gains per Quarter (151 shares)-23.727.09
Gains per Year (151 shares)-94.8928.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-95-10524418
20-190-20049846
30-285-295731274
40-380-3909716102
50-474-48512220130
60-569-58014624158
70-664-67517028186
80-759-77019432214
90-854-86521937242
100-949-96024341270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%5.07.00.041.7%12.08.00.060.0%25.08.00.075.8%25.08.00.075.8%
Book Value Change Per Share0.04.00.00.0%5.07.00.041.7%11.09.00.055.0%23.010.00.069.7%23.010.00.069.7%
Dividend per Share0.00.04.00.0%6.00.06.050.0%14.00.06.070.0%23.00.010.069.7%23.00.010.069.7%
Total Gains per Share0.04.00.00.0%6.06.00.050.0%13.07.00.065.0%26.07.00.078.8%26.07.00.078.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Daesung Microbiological Labs. Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---293.389-224.440-24%37.579-881%9.601-3156%284.163-203%
Book Value Per Share--9377.3869713.576-3%10200.368-8%9739.119-4%8958.611+5%
Current Ratio--2.7002.765-2%2.866-6%5.007-46%5.209-48%
Debt To Asset Ratio--0.4000.411-3%0.404-1%0.384+4%0.298+34%
Debt To Equity Ratio--0.6650.698-5%0.680-2%0.633+5%0.429+55%
Dividend Per Share----0%56.250-100%57.500-100%58.485-100%
Enterprise Value--15653798000.00014388182700.000+9%25511122212.500-39%38249749870.000-59%146186671847.899-89%
Eps---293.389-171.209-42%28.986-1112%34.317-955%108.516-370%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.6980.605+15%1.052-34%1.602-56%5.664-88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap35796000000.000-10%39368000000.00040166000000.000-2%39320500000.000+0%52253800000.000-25%156955849624.868-75%
Net Profit Margin---0.199-0.115-42%0.017-1293%0.017-1285%0.057-449%
Operating Margin----0%-0.0170%0.000-100%0.052-100%
Operating Ratio--1.9351.962-1%1.436+35%1.215+59%1.347+44%
Pb Ratio1.005-10%1.1051.089+1%1.014+9%1.420-22%5.386-79%
Pe Ratio-8.027+9%-8.828-74.279+741%-193.818+2096%17.956-149%81.111-111%
Price Per Share9420.000-10%10360.00010570.000-2%10347.500+0%13751.000-25%41303.637-75%
Price To Free Cash Flow Ratio---0.711-100%-0.1020%-9.0170%-9.1110%
Price To Total Gains Ratio-32.108+9%-35.311-52.656+49%-3.841-89%-191.894+443%82.615-143%
Quick Ratio---0.858-100%2.476-100%3.747-100%3.093-100%
Return On Assets---0.019-0.011-44%0.002-1239%0.002-906%0.011-273%
Return On Equity---0.031-0.018-43%0.003-1207%0.003-998%0.008-468%
Total Gains Per Share---293.389-224.440-24%93.829-413%67.101-537%342.648-186%
Usd Book Value--24943845.50025838113.030-3%27132979.767-8%25906056.058-4%23829972.207+5%
Usd Book Value Change Per Share---0.205-0.157-24%0.026-881%0.007-3156%0.199-203%
Usd Book Value Per Share--6.5646.800-3%7.140-8%6.817-4%6.271+5%
Usd Dividend Per Share----0%0.039-100%0.040-100%0.041-100%
Usd Enterprise Value--10957658.60010071727.890+9%17857785.549-39%26774824.909-59%102330670.294-89%
Usd Eps---0.205-0.120-42%0.020-1112%0.024-955%0.076-370%
Usd Free Cash Flow----254913.5660%-565029.3930%-1144502.0250%-526775.8250%
Usd Market Cap25057200.000-10%27557600.00028116200.000-2%27524350.000+0%36577660.000-25%109869094.737-75%
Usd Price Per Share6.594-10%7.2527.399-2%7.243+0%9.626-25%28.913-75%
Usd Profit---780414.600-455415.118-42%77103.495-1112%91282.341-955%288656.292-370%
Usd Revenue--3922793.0004201604.134-7%4339254.150-10%4282006.099-8%4472864.680-12%
Usd Total Gains Per Share---0.205-0.157-24%0.066-413%0.047-537%0.240-186%
 EOD+3 -4MRQTTM+9 -21YOY+5 -265Y+4 -2810Y+6 -26

3.3 Fundamental Score

Let's check the fundamental score of Daesung Microbiological Labs. Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.027
Price to Book Ratio (EOD)Between0-11.005
Net Profit Margin (MRQ)Greater than0-0.199
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.700
Debt to Asset Ratio (MRQ)Less than10.400
Debt to Equity Ratio (MRQ)Less than10.665
Return on Equity (MRQ)Greater than0.15-0.031
Return on Assets (MRQ)Greater than0.05-0.019
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Daesung Microbiological Labs. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.796
Ma 20Greater thanMa 509,445.000
Ma 50Greater thanMa 1009,737.200
Ma 100Greater thanMa 2009,827.900
OpenGreater thanClose9,460.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Daesung Microbiological Labs. Co. Ltd

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 15:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Daesung Microbiological Labs. Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -19.9% means that ₩-0.20 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is -19.9%. The company is making a huge loss. -2
  • The TTM is -11.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-19.9%TTM-11.5%-8.4%
TTM-11.5%YOY1.7%-13.2%
TTM-11.5%5Y1.7%-13.2%
5Y1.7%10Y5.7%-4.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.9%-108.6%+88.7%
TTM-11.5%-220.8%+209.3%
YOY1.7%-207.5%+209.2%
5Y1.7%-350.0%+351.7%
10Y5.7%-473.2%+478.9%
4.3.1.2. Return on Assets

Shows how efficient Daesung Microbiological Labs. Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • -1.9% Return on Assets means that Daesung Microbiological Labs. Co. Ltd generated ₩-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is -1.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM-1.1%-0.8%
TTM-1.1%YOY0.2%-1.2%
TTM-1.1%5Y0.2%-1.3%
5Y0.2%10Y1.1%-0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.9%-11.6%+9.7%
TTM-1.1%-11.9%+10.8%
YOY0.2%-11.2%+11.4%
5Y0.2%-12.6%+12.8%
10Y1.1%-14.2%+15.3%
4.3.1.3. Return on Equity

Shows how efficient Daesung Microbiological Labs. Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • -3.1% Return on Equity means Daesung Microbiological Labs. Co. Ltd generated ₩-0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is -3.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM-1.8%-1.4%
TTM-1.8%YOY0.3%-2.1%
TTM-1.8%5Y0.3%-2.1%
5Y0.3%10Y0.8%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-14.3%+11.2%
TTM-1.8%-15.9%+14.1%
YOY0.3%-14.7%+15.0%
5Y0.3%-18.5%+18.8%
10Y0.8%-19.2%+20.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Daesung Microbiological Labs. Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Daesung Microbiological Labs. Co. Ltd is operating .

  • Measures how much profit Daesung Microbiological Labs. Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1.7%+1.7%
TTM-5Y0.0%0.0%
5Y0.0%10Y5.2%-5.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.0%+204.0%
TTM--316.3%+316.3%
YOY-1.7%-216.2%+214.5%
5Y0.0%-379.8%+379.8%
10Y5.2%-480.9%+486.1%
4.3.2.2. Operating Ratio

Measures how efficient Daesung Microbiological Labs. Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.93 means that the operating costs are ₩1.93 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 1.935. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.962. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.935TTM1.962-0.028
TTM1.962YOY1.436+0.527
TTM1.9625Y1.215+0.747
5Y1.21510Y1.347-0.132
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9352.284-0.349
TTM1.9623.244-1.282
YOY1.4363.247-1.811
5Y1.2154.764-3.549
10Y1.3476.437-5.090
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Daesung Microbiological Labs. Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Daesung Microbiological Labs. Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.70 means the company has ₩2.70 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 2.700. The company is able to pay all its short-term debts. +1
  • The TTM is 2.765. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.700TTM2.765-0.065
TTM2.765YOY2.866-0.101
TTM2.7655Y5.007-2.242
5Y5.00710Y5.209-0.201
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7003.586-0.886
TTM2.7653.865-1.100
YOY2.8664.644-1.778
5Y5.0075.968-0.961
10Y5.2096.215-1.006
4.4.3.2. Quick Ratio

Measures if Daesung Microbiological Labs. Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.858-0.858
TTM0.858YOY2.476-1.618
TTM0.8585Y3.747-2.889
5Y3.74710Y3.093+0.654
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.099-3.099
TTM0.8583.384-2.526
YOY2.4764.304-1.828
5Y3.7475.954-2.207
10Y3.0936.436-3.343
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Daesung Microbiological Labs. Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Daesung Microbiological Labs. Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.40 means that Daesung Microbiological Labs. Co. Ltd assets are financed with 40.0% credit (debt) and the remaining percentage (100% - 40.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 0.400. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.411. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.400TTM0.411-0.011
TTM0.411YOY0.404+0.007
TTM0.4115Y0.384+0.027
5Y0.38410Y0.298+0.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4000.346+0.054
TTM0.4110.346+0.065
YOY0.4040.314+0.090
5Y0.3840.365+0.019
10Y0.2980.383-0.085
4.5.4.2. Debt to Equity Ratio

Measures if Daesung Microbiological Labs. Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 66.5% means that company has ₩0.67 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 0.665. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.698. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.665TTM0.698-0.033
TTM0.698YOY0.680+0.018
TTM0.6985Y0.633+0.065
5Y0.63310Y0.429+0.204
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6650.393+0.272
TTM0.6980.432+0.266
YOY0.6800.390+0.290
5Y0.6330.452+0.181
10Y0.4290.498-0.069
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Daesung Microbiological Labs. Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Daesung Microbiological Labs. Co. Ltd to the Biotechnology industry mean.
  • A PE ratio of -8.83 means the investor is paying ₩-8.83 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The EOD is -8.027. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.828. Based on the earnings, the company is expensive. -2
  • The TTM is -74.279. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.027MRQ-8.828+0.801
MRQ-8.828TTM-74.279+65.451
TTM-74.279YOY-193.818+119.539
TTM-74.2795Y17.956-92.235
5Y17.95610Y81.111-63.155
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.027-2.123-5.904
MRQ-8.828-2.548-6.280
TTM-74.279-3.161-71.118
YOY-193.818-3.244-190.574
5Y17.956-6.006+23.962
10Y81.111-6.717+87.828
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.711-0.711
TTM0.711YOY-0.102+0.813
TTM0.7115Y-9.017+9.728
5Y-9.01710Y-9.111+0.094
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.295+3.295
TTM0.711-3.674+4.385
YOY-0.102-4.477+4.375
5Y-9.017-8.046-0.971
10Y-9.111-9.204+0.093
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Daesung Microbiological Labs. Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.10 means the investor is paying ₩1.10 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Daesung Microbiological Labs. Co. Ltd:

  • The EOD is 1.005. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.105. Based on the equity, the company is underpriced. +1
  • The TTM is 1.089. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.005MRQ1.105-0.100
MRQ1.105TTM1.089+0.016
TTM1.089YOY1.014+0.074
TTM1.0895Y1.420-0.332
5Y1.42010Y5.386-3.966
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0051.919-0.914
MRQ1.1052.055-0.950
TTM1.0892.389-1.300
YOY1.0142.454-1.440
5Y1.4203.716-2.296
10Y5.3864.373+1.013
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets59,348,267
Total Liabilities23,714,202
Total Stockholder Equity35,634,066
 As reported
Total Liabilities 23,714,202
Total Stockholder Equity+ 35,634,066
Total Assets = 59,348,267

Assets

Total Assets59,348,267
Total Current Assets24,605,194
Long-term Assets34,743,074
Total Current Assets
Total Current Assets  (as reported)24,605,194
Total Current Assets  (calculated)0
+/- 24,605,194
Long-term Assets
Long-term Assets  (as reported)34,743,074
Long-term Assets  (calculated)0
+/- 34,743,074

Liabilities & Shareholders' Equity

Total Current Liabilities9,114,006
Long-term Liabilities14,600,196
Total Stockholder Equity35,634,066
Total Current Liabilities
Total Current Liabilities  (as reported)9,114,006
Total Current Liabilities  (calculated)0
+/- 9,114,006
Long-term Liabilities
Long-term Liabilities  (as reported)14,600,196
Long-term Liabilities  (calculated)0
+/- 14,600,196
Total Stockholder Equity
Total Stockholder Equity (as reported)35,634,066
Total Stockholder Equity (calculated)0
+/- 35,634,066
Other
Common Stock Shares Outstanding 3,800
Net Working Capital 15,491,188



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-03-312015-12-312015-09-302015-06-30
> Total Assets 
30,934,000
29,190,000
32,419,000
33,783,000
34,549,075
34,660,800
34,782,459
34,930,197
36,655,504
35,605,872
38,098,477
38,697,782
44,235,643
44,657,619
50,767,498
52,462,873
55,462,188
57,247,117
62,262,935
61,465,043
62,004,898
60,971,129
62,620,090
65,316,263
63,933,908
62,867,948
65,109,305
65,445,579
67,022,897
64,335,068
64,290,285
62,784,009
59,348,267
59,348,26762,784,00964,290,28564,335,06867,022,89765,445,57965,109,30562,867,94863,933,90865,316,26362,620,09060,971,12962,004,89861,465,04362,262,93557,247,11755,462,18852,462,87350,767,49844,657,61944,235,64338,697,78238,098,47735,605,87236,655,50434,930,19734,782,45934,660,80034,549,07533,783,00032,419,00029,190,00030,934,000
   > Total Current Assets 
15,053,000
13,425,000
16,970,000
18,315,000
19,442,452
18,835,756
19,170,204
19,327,818
21,038,574
19,991,951
22,999,723
23,605,522
24,944,963
23,168,133
25,039,055
24,376,833
24,938,589
24,748,187
23,757,320
22,686,555
23,324,615
21,798,998
23,722,143
28,838,509
28,312,218
26,549,321
28,690,269
28,981,823
30,719,553
28,109,058
28,717,022
27,509,429
24,605,194
24,605,19427,509,42928,717,02228,109,05830,719,55328,981,82328,690,26926,549,32128,312,21828,838,50923,722,14321,798,99823,324,61522,686,55523,757,32024,748,18724,938,58924,376,83325,039,05523,168,13324,944,96323,605,52222,999,72319,991,95121,038,57419,327,81819,170,20418,835,75619,442,45218,315,00016,970,00013,425,00015,053,000
       Cash And Cash Equivalents 
3,345,000
3,336,000
6,522,000
5,680,000
3,698,372
3,884,007
5,247,195
4,674,478
6,265,137
5,308,385
4,942,628
7,086,716
7,647,024
5,890,103
8,251,945
5,255,004
7,056,163
5,954,380
5,211,781
5,408,760
5,477,025
4,000,867
4,395,195
0
0
0
3,851,757
3,378,166
4,190,540
3,175,515
4,362,435
2,857,784
0
02,857,7844,362,4353,175,5154,190,5403,378,1663,851,7570004,395,1954,000,8675,477,0255,408,7605,211,7815,954,3807,056,1635,255,0048,251,9455,890,1037,647,0247,086,7164,942,6285,308,3856,265,1374,674,4785,247,1953,884,0073,698,3725,680,0006,522,0003,336,0003,345,000
       Short-term Investments 
1,195,000
1,224,000
1,561,000
2,501,000
4,817,950
4,153,690
3,918,480
3,863,016
3,858,042
3,887,581
6,231,442
3,375,527
5,843,112
5,576,748
4,252,000
0
0
5,955,717
4,840,032
4,898,157
5,394,590
5,249,281
5,539,327
6,756,424
10,638,318
9,405,474
9,007,077
7,664,661
9,295,686
8,197,902
7,365,053
7,375,955
0
07,375,9557,365,0538,197,9029,295,6867,664,6619,007,0779,405,47410,638,3186,756,4245,539,3275,249,2815,394,5904,898,1574,840,0325,955,717004,252,0005,576,7485,843,1123,375,5276,231,4423,887,5813,858,0423,863,0163,918,4804,153,6904,817,9502,501,0001,561,0001,224,0001,195,000
       Net Receivables 
4,481,000
3,050,000
3,284,000
4,071,000
3,838,219
4,139,266
2,971,325
3,793,252
2,993,501
3,836,112
3,862,708
4,087,367
3,618,052
2,929,842
2,970,011
4,128,953
3,078,175
3,648,030
3,729,977
3,172,957
3,593,423
3,769,644
3,058,446
3,094,891
3,065,069
3,079,700
3,195,870
3,385,546
3,145,522
3,644,116
4,130,869
3,888,318
0
03,888,3184,130,8693,644,1163,145,5223,385,5463,195,8703,079,7003,065,0693,094,8913,058,4463,769,6443,593,4233,172,9573,729,9773,648,0303,078,1754,128,9532,970,0112,929,8423,618,0524,087,3673,862,7083,836,1122,993,5013,793,2522,971,3254,139,2663,838,2194,071,0003,284,0003,050,0004,481,000
       Inventory 
5,977,000
5,771,000
5,543,000
6,007,000
7,020,142
6,615,266
6,786,335
6,962,778
7,887,775
6,915,017
7,928,584
9,028,017
7,796,494
8,602,340
9,265,922
8,519,611
8,676,663
9,072,744
9,196,698
8,981,262
8,750,685
8,684,784
10,613,921
11,513,134
10,447,373
10,586,755
11,641,334
14,395,123
13,986,606
12,817,812
12,499,377
12,995,683
0
012,995,68312,499,37712,817,81213,986,60614,395,12311,641,33410,586,75510,447,37311,513,13410,613,9218,684,7848,750,6858,981,2629,196,6989,072,7448,676,6638,519,6119,265,9228,602,3407,796,4949,028,0177,928,5846,915,0177,887,7756,962,7786,786,3356,615,2667,020,1426,007,0005,543,0005,771,0005,977,000
       Other Current Assets 
17,000
9,000
9,000
3,000
9,254
1,688
216,742
7,635
116
5,581
2,183
583
4,839
3,198
641
2,024
9,350
1,558
163,603
164,815
50,938
49,793
0
0
59,802
59,934
958,975
0
0
0
0
0
0
000000958,97559,93459,8020049,79350,938164,815163,6031,5589,3502,0246413,1984,8395832,1835,5811167,635216,7421,6889,2543,0009,0009,00017,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,419,036
36,463,756
36,303,344
36,226,010
35,573,263
35,274,581
34,743,074
34,743,07435,274,58135,573,26336,226,01036,303,34436,463,75636,419,03600000000000000000000000000
       Property Plant Equipment 
0
0
0
0
12,512,631
13,086,371
13,020,770
12,936,562
12,875,109
12,751,178
12,634,347
12,464,187
16,382,692
18,431,357
23,147,052
25,360,133
27,035,378
28,741,538
35,284,565
35,314,088
35,514,506
35,696,503
35,845,796
33,166,574
32,857,983
33,397,842
33,302,614
33,148,377
32,721,645
32,306,061
32,123,789
31,563,800
0
031,563,80032,123,78932,306,06132,721,64533,148,37733,302,61433,397,84232,857,98333,166,57435,845,79635,696,50335,514,50635,314,08835,284,56528,741,53827,035,37825,360,13323,147,05218,431,35716,382,69212,464,18712,634,34712,751,17812,875,10912,936,56213,020,77013,086,37112,512,6310000
       Long Term Investments 
734,000
860,000
461,000
569,000
691,600
850,600
607,600
751,600
904,600
1,067,600
645,600
825,600
1,034,600
1,308,100
796,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000796,1001,308,1001,034,600825,600645,6001,067,600904,600751,600607,600850,600691,600569,000461,000860,000734,000
       Intangible Assets 
0
0
0
0
362,056
361,679
360,763
361,109
360,905
360,339
359,772
361,177
360,548
1,180,664
1,132,062
1,095,441
1,512,892
1,456,363
1,204,216
1,160,566
1,161,192
1,117,523
1,073,579
1,023,608
973,706
923,465
873,689
824,837
775,515
731,612
686,854
645,977
0
0645,977686,854731,612775,515824,837873,689923,465973,7061,023,6081,073,5791,117,5231,161,1921,160,5661,204,2161,456,3631,512,8921,095,4411,132,0621,180,664360,548361,177359,772360,339360,905361,109360,763361,679362,0560000
       Other Assets 
0
0
0
0
1,540,336
1,526,394
1,623,121
1,553,108
1,476,316
1,434,804
1,459,035
1,441,296
1,512,840
573,565
1,425,689
1,333,601
1,794,534
1,740,021
1,516,678
1,473,318
1,400,938
1,431,100
651,175
650,175
1,249,475
1,092,024
1,505,802
934,749
1,220,456
0
0
0
0
00001,220,456934,7491,505,8021,092,0241,249,475650,175651,1751,431,1001,400,9381,473,3181,516,6781,740,0211,794,5341,333,6011,425,689573,5651,512,8401,441,2961,459,0351,434,8041,476,3161,553,1081,623,1211,526,3941,540,3360000
> Total Liabilities 
7,292,000
5,151,000
7,325,000
7,889,000
4,879,295
4,655,650
4,485,961
4,668,596
5,546,808
3,718,732
5,089,192
5,269,412
9,331,218
9,663,882
15,676,323
16,916,292
19,063,034
20,582,506
25,951,597
25,451,030
25,569,579
24,870,813
25,616,477
26,869,400
25,459,559
24,409,883
26,271,895
26,741,003
27,977,349
26,420,342
26,941,660
26,035,065
23,714,202
23,714,20226,035,06526,941,66026,420,34227,977,34926,741,00326,271,89524,409,88325,459,55926,869,40025,616,47724,870,81325,569,57925,451,03025,951,59720,582,50619,063,03416,916,29215,676,3239,663,8829,331,2185,269,4125,089,1923,718,7325,546,8084,668,5964,485,9614,655,6504,879,2957,889,0007,325,0005,151,0007,292,000
   > Total Current Liabilities 
5,160,000
2,987,000
5,912,000
6,464,000
3,219,279
3,048,518
3,079,520
3,279,011
4,380,103
2,431,134
3,712,594
3,871,029
2,783,441
3,221,412
3,133,158
2,530,564
2,987,768
2,628,632
4,578,202
3,371,819
3,966,623
3,871,822
5,314,658
7,420,403
8,667,024
8,099,833
10,610,934
11,583,671
10,303,704
9,314,562
10,398,314
10,658,555
9,114,006
9,114,00610,658,55510,398,3149,314,56210,303,70411,583,67110,610,9348,099,8338,667,0247,420,4035,314,6583,871,8223,966,6233,371,8194,578,2022,628,6322,987,7682,530,5643,133,1583,221,4122,783,4413,871,0293,712,5942,431,1344,380,1033,279,0113,079,5203,048,5183,219,2796,464,0005,912,0002,987,0005,160,000
       Short-term Debt 
2,495,000
1,995,000
1,995,000
1,995,000
1,373,200
298,800
274,400
250,000
250,000
187,500
125,000
62,500
0
700,000
700,000
700,000
700,000
700,000
877,562
700,000
777,970
700,000
700,000
700,000
700,000
700,000
2,000,000
3,000,000
5,000,000
0
0
0
0
00005,000,0003,000,0002,000,000700,000700,000700,000700,000700,000777,970700,000877,562700,000700,000700,000700,000700,000062,500125,000187,500250,000250,000274,400298,8001,373,2001,995,0001,995,0001,995,0002,495,000
       Short Long Term Debt 
2,495,000
1,995,000
1,995,000
1,995,000
1,373,200
298,800
274,400
250,000
250,000
187,500
125,000
62,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,350,000
7,000,000
7,000,000
7,062,500
7,443,634
7,887,500
0
07,887,5007,443,6347,062,5007,000,0007,000,0006,350,0000000000000000062,500125,000187,500250,000250,000274,400298,8001,373,2001,995,0001,995,0001,995,0002,495,000
       Accounts payable 
2,221,000
789,000
2,450,000
2,757,000
987,094
1,188,316
1,203,346
1,107,601
2,516,197
423,069
1,847,881
1,874,082
897,699
1,638,282
1,812,960
645,239
1,159,166
918,659
1,237,133
669,512
1,154,134
644,791
0
0
704,341
637,980
977,936
957,109
1,406,000
771,009
1,543,200
1,257,117
0
01,257,1171,543,200771,0091,406,000957,109977,936637,980704,34100644,7911,154,134669,5121,237,133918,6591,159,166645,2391,812,9601,638,282897,6991,874,0821,847,881423,0692,516,1971,107,6011,203,3461,188,316987,0942,757,0002,450,000789,0002,221,000
       Other Current Liabilities 
436,000
287,000
434,000
631,000
370,142
264,900
338,912
556,854
400,381
780,093
655,002
955,541
173,273
84,004
106,375
428,704
166,403
102,893
111,306
548,994
181,467
134,273
0
0
1,156,107
106,772
501,626
0
0
0
0
0
0
000000501,626106,7721,156,10700134,273181,467548,994111,306102,893166,403428,704106,37584,004173,273955,541655,002780,093400,381556,854338,912264,900370,142631,000434,000287,000436,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,660,961
15,157,332
17,673,646
17,105,779
16,543,347
15,376,510
14,600,196
14,600,19615,376,51016,543,34717,105,77917,673,64615,157,33215,660,96100000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,143,109
11,143,109
12,843,218
14,738,633
16,695,483
20,852,119
21,552,119
21,064,746
20,523,304
19,976,505
19,126,505
16,537,389
16,045,649
15,538,449
15,034,820
17,551,134
0
0
0
0
000017,551,13415,034,82015,538,44916,045,64916,537,38919,126,50519,976,50520,523,30421,064,74621,552,11920,852,11916,695,48314,738,63312,843,21811,143,1095,143,1090000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179,277
131,277
109,615
243,201
192,645
275,115
0
0275,115192,645243,201109,615131,277179,27700000000000000000000000000
       Other Liabilities 
0
0
0
0
1,410,016
1,607,132
1,281,440
1,327,085
1,166,705
1,287,598
1,376,598
1,398,383
1,404,668
1,299,361
1,400,056
1,542,511
1,336,633
1,258,391
521,277
527,091
538,210
475,687
0
0
255,146
264,401
122,512
0
0
0
0
0
0
000000122,512264,401255,14600475,687538,210527,091521,2771,258,3911,336,6331,542,5111,400,0561,299,3611,404,6681,398,3831,376,5981,287,5981,166,7051,327,0851,281,4401,607,1321,410,0160000
> Total Stockholder Equity
0
0
0
0
29,669,781
30,005,150
30,296,498
30,261,601
31,108,696
31,887,140
33,009,285
33,428,370
34,904,425
34,993,737
35,091,175
35,546,581
36,399,154
36,664,612
36,311,338
36,014,013
36,435,319
36,100,316
37,003,613
38,446,864
38,474,349
38,458,065
38,837,410
38,704,576
39,045,548
37,914,726
37,348,625
36,748,944
35,634,066
35,634,06636,748,94437,348,62537,914,72639,045,54838,704,57638,837,41038,458,06538,474,34938,446,86437,003,61336,100,31636,435,31936,014,01336,311,33836,664,61236,399,15435,546,58135,091,17534,993,73734,904,42533,428,37033,009,28531,887,14031,108,69630,261,60130,296,49830,005,15029,669,7810000
   Common Stock
4,984,000
4,984,000
4,984,000
4,984,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
1,900,000
0
0
0
0
00001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0001,900,0004,984,0004,984,0004,984,0004,984,000
   Retained Earnings Total Equity000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
6,241,160
6,241,160
6,241,160
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
3,084,659
0
0
0
0
00003,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6593,084,6596,241,1606,241,1606,241,1600000000000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
3,157,001
3,157,000
3,157,000
3,157,000
0
3,156,501
3,157,000
3,157,000
3,157,000
3,157,000
2,714,198
2,714,198
3,156,501
3,156,501
3,159,586
3,159,586
3,158,939
3,158,939
0
0
3,159,586
3,159,586
3,159,620
0
0
0
0
0
0
0000003,159,6203,159,5863,159,586003,158,9393,158,9393,159,5863,159,5863,156,5013,156,5012,714,1982,714,1983,157,0003,157,0003,157,0003,157,0003,156,50103,157,0003,157,0003,157,0003,157,0010000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue25,562,323
Cost of Revenue-20,712,864
Gross Profit4,849,4594,849,459
 
Operating Income (+$)
Gross Profit4,849,459
Operating Expense-26,251,334
Operating Income-689,011-21,401,875
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,078,492
Selling And Marketing Expenses0
Operating Expense26,251,3342,078,492
 
Net Interest Income (+$)
Interest Income374,423
Interest Expense-892,666
Other Finance Cost-0
Net Interest Income-518,243
 
Pretax Income (+$)
Operating Income-689,011
Net Interest Income-518,243
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,081,728-689,011
EBIT - interestExpense = -892,666
-679,676
212,990
Interest Expense892,666
Earnings Before Interest and Taxes (EBIT)0-189,062
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,081,728
Tax Provision--402,053
Net Income From Continuing Ops-679,676-679,676
Net Income-679,676
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0518,243
 

Technical Analysis of Daesung Microbiological Labs. Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Daesung Microbiological Labs. Co. Ltd. The general trend of Daesung Microbiological Labs. Co. Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Daesung Microbiological Labs. Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Daesung Microbiological Labs. Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9,800 < 9,800 < 9,830.

The bearish price targets are: 8,560 > 8,460.

Tweet this
Daesung Microbiological Labs. Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Daesung Microbiological Labs. Co. Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Daesung Microbiological Labs. Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Daesung Microbiological Labs. Co. Ltd. The current macd is -64.04209935.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Daesung Microbiological Labs. Co. Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Daesung Microbiological Labs. Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Daesung Microbiological Labs. Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Daesung Microbiological Labs. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDaesung Microbiological Labs. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Daesung Microbiological Labs. Co. Ltd. The current adx is 17.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Daesung Microbiological Labs. Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Daesung Microbiological Labs. Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Daesung Microbiological Labs. Co. Ltd. The current sar is 8,664.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Daesung Microbiological Labs. Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Daesung Microbiological Labs. Co. Ltd. The current rsi is 47.80. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Daesung Microbiological Labs. Co. Ltd Daily Relative Strength Index (RSI) ChartDaesung Microbiological Labs. Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Daesung Microbiological Labs. Co. Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Daesung Microbiological Labs. Co. Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Daesung Microbiological Labs. Co. Ltd Daily Stochastic Oscillator ChartDaesung Microbiological Labs. Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Daesung Microbiological Labs. Co. Ltd. The current cci is -16.10614446.

Daesung Microbiological Labs. Co. Ltd Daily Commodity Channel Index (CCI) ChartDaesung Microbiological Labs. Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Daesung Microbiological Labs. Co. Ltd. The current cmo is -2.78821892.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Daesung Microbiological Labs. Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartDaesung Microbiological Labs. Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Daesung Microbiological Labs. Co. Ltd. The current willr is -35.82089552.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Daesung Microbiological Labs. Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Daesung Microbiological Labs. Co. Ltd Daily Williams %R ChartDaesung Microbiological Labs. Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Daesung Microbiological Labs. Co. Ltd.

Daesung Microbiological Labs. Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Daesung Microbiological Labs. Co. Ltd. The current atr is 331.24.

Daesung Microbiological Labs. Co. Ltd Daily Average True Range (ATR) ChartDaesung Microbiological Labs. Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Daesung Microbiological Labs. Co. Ltd. The current obv is 31,038,453.

Daesung Microbiological Labs. Co. Ltd Daily On-Balance Volume (OBV) ChartDaesung Microbiological Labs. Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Daesung Microbiological Labs. Co. Ltd. The current mfi is 40.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Daesung Microbiological Labs. Co. Ltd Daily Money Flow Index (MFI) ChartDaesung Microbiological Labs. Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Daesung Microbiological Labs. Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Daesung Microbiological Labs. Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Daesung Microbiological Labs. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.796
Ma 20Greater thanMa 509,445.000
Ma 50Greater thanMa 1009,737.200
Ma 100Greater thanMa 2009,827.900
OpenGreater thanClose9,460.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Daesung Microbiological Labs. Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Daesung Microbiological Labs. Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Daesung Microbiological Labs. Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Daesung Microbiological Labs. Co. Ltd

I send you an email if I find something interesting about Daesung Microbiological Labs. Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Daesung Microbiological Labs. Co. Ltd.

Receive notifications about Daesung Microbiological Labs. Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.